Related Experiment Video
Updated: May 28, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Ethical dilemmas in antibiotic treatment
Leonard Leibovici1, Mical Paul, Ovadia Ezra
1Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Israel. leibovic@post.tau.ac.il
Abstract:
Patients with moderate to severe infections are given less than maximum empirical antibiotic treatment in order to reduce the rise in resistance. This practice involves two ethical dilemmas: whether the danger to a present patient should be increased (even if by a small degree) to benefit future, unidentified patients; and whether this should be done without the consent of the patient, disregarding the patient's autonomy. We argue that future patients have a right to come to no harm. Future patients being unidentified, practitioners of medicine have a duty to protect their rights and weigh them against the rights of the present patient. A decision on the collective (guidelines, decision support systems) is a convenient way to do that. Using a temporal discount rate to show that the life of present patients has pre-eminence, to some degree, over future patients does not solve the immediacy of the plight facing a present, identified patient with a very severe infection. We think there are good grounds to take into less account considerations of future resistance for such a patient, or in a formal analysis, to make the ratio of benefits to the present versus future patients dependent on the severity of disease of the present patient. None of these solve the problem of patients' autonomy. We see no other way but to argue that the right of future patients to come to less harm outweighs the right of the present patient to share in decisions on antibiotic treatment.
Insights
To reduce antibiotic resistance, current patients may receive less than maximum treatment. This study argues future patients' right to safety outweighs present patients' autonomy in treatment decisions.
Area of Science:
- Medical Ethics
- Infectious Diseases
- Pharmacology
Background:
- Empirical antibiotic treatment is often reduced for moderate to severe infections to mitigate antibiotic resistance.
- This practice raises ethical concerns regarding patient autonomy and the balance between present and future patient welfare.
Purpose of the Study:
- To explore the ethical dilemmas of under-treating current patients to prevent future antibiotic resistance.
- To weigh the rights of present patients against the rights of future, unidentified patients.
Main Methods:
- Ethical analysis of competing patient rights.
- Consideration of collective decision-making frameworks (guidelines, decision support systems).
- Discussion of temporal discounting and disease severity in ethical calculations.
Main Results:
- Collective decision-making offers a practical approach to balancing present and future patient interests.
- The severity of a present patient's condition may warrant prioritizing their immediate needs over long-term resistance concerns.
- Patient autonomy is challenged, as future patients' right to be free from harm is argued to supersede the present patient's right to shared decision-making.
Conclusions:
- The right of future patients to be free from harm due to antibiotic resistance should be prioritized.
- While patient autonomy is crucial, in this context, it must be carefully balanced against the collective good.
- Ethical guidelines and decision support systems are essential for navigating these complex treatment decisions.
Related Concept Videos
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Issues
Ethical Concerns in Healthcare:
Antibiotic Selection
Ethical Dilemmas II
Microbiota Modulation by Antibiotics
Development of Antibiotic Resistance
